Showing 2381-2390 of 3315 results for "".
- Novartis: New Analysis of Phase 3 Brolucizumab Data Reinforces Superior Reduction of Retinal Fluidhttps://modernod.com/news/novartis-new-analysis-of-phase-3-brolucizumab-data-reinforces-superior-reduction-of-retinal-fluid/2479846/Novartis announced a new data analysis showing that retinal fluid was detected less often in patients treated with brolucizumab (RTH258) 6 mg versus aflibercept over four visits between weeks 36 to 48[1]. Retinal fluid is a key marker of disease activity in neovascular age-related macular degener
- Optos Launches Monaco Ultra-Widefield Retinal Imaging Systemhttps://modernod.com/news/optos-launches-monaco-ultra-widefield-retinal-imaging-system/2479855/Optos has launched Monaco, its latest ultra-widefield device to the European ophthalmic market. Monaco is the only ultra-widefield retinal imaging system with integrated Optical Coherence Tomography (OCT), according to Optos. It produces a 200° single-capture optomap image in less than hal
- Allegro Prepares To Take Lead Compound Risuteganib To Phase 3, Appoints New CEOhttps://modernod.com/news/allegro-prepares-to-take-lead-compound-risuteganib-to-phase-3-appoints-new-ceo/2479926/Allegro Ophthalmics announced that its board of directors has named Hampar Karageozian to the position of Executive Chairman and has appointed Vicken Karageozian, MD, to the position of President and Chief Executive O
- Eye Conditions Provide New Lens for Screening for Alzheimer Diseasehttps://modernod.com/news/eye-conditions-provide-new-lens-for-screening-for-alzheimer-disease/2479952/A study of 3,877 randomly selected patients suggested a significant link between three degenerative eye diseases—age-related macular degeneration, diabetic retinopathy, and glaucoma—and Alzheimer disease. The results offer physicians a new way to detect those at higher risk of this disord
- Family Income, Ethnicity, and Health Literacy May Affect Children’s Vision, Eye Care Accesshttps://modernod.com/news/family-income-ethnicity-and-health-literacy-may-affect-childrens-vision-eye-care-access/2479982/August for many children in the United States is the beginning of a brand new school year. According to the recent report from the National Center for Children’s Vision and Eye H
- Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Boardhttps://modernod.com/news/alzheimers-therapeutics-research-leader-dr-roy-twyman-joins-neurovision-imaging-board/2480013/Roy Ervin Twyman, MD, PhD, an academic neurologist with nearly 20 years’ experience in neuroscience pharmaceutical drug development, will join the NeuroVision Imaging Board of Directors on July 20. NeuroVision is developing and studying an experimental, breakthrough, low-cost, noninvasive,
- SynergEyes and Brien Holden Vision Institute Join Forces for Specialty Contact Lens Developmenthttps://modernod.com/news/synergeyes-and-brien-holden-vision-institute-join-forces-for-specialty-contact-lens-development/2480098/SynergEyes announced a new partnership with the Brien Holden Vision Institute, a translational vision correction center that delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies
- Johnson & Johnson Vision Presents New Data on Silicone Hydrogel Contact Lens Muco-Adhesive Propertieshttps://modernod.com/news/johnson-johnson-vision-presents-new-data-on-silicone-hydrogel-contact-lens-muco-adhesive-properties/2480192/Johnson & Johnson Vision presented new data at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Honolulu, Hawaii. The data measured how the extent of crosslinking affects muco-adhesion in a laboratory study with corneal epithel
- WCO, Alcon Update Dry Eye Wheel with TFOS DEWS III Recommendationshttps://modernod.com/news/wco-alcon-update-dry-eye-wheel-with-tfos-dews-iii-recommendations/2487506/Key Takeaways WCO and Alcon have updated the WCO Alcon Dry Eye Wheel to align with recommendations from the TFOS DEWS III report New features include dry eye etiological drivers, the OSDI-6 questionnaire, and expanded management guidance<
- CooperVision Completes National Campaign on Childhood Myopiahttps://modernod.com/news/coopervision-completes-national-campaign-on-childhood-myopia/2487078/Key Takeaways CooperVision launched a nationwide media campaign focused on raising awareness about childhood myopia and promoting early diagnosis, intervention, and proactive treatment. The campaign was led by Damaris Raymondi, OD, and Coralys Vega, MD, who